@article{49e54a938eb5464ab4e7232948521b92,
title = "Response to comment on “International consensus recommendations for the use of prolonged-infusion β-lactams endorsed by the American College of Clinical Pharmacy (ACCP), the British Society for Antimicrobial Chemotherapy (BSAC), the Cystic Fibrosis Foundation (CFF), the European Society of Clinical Microbiology and Infectious Diseases (ESCMID), the Infectious Diseases Society of American (IDSA), the Society of Critical Care Medicine (SCCM), and the Society of Infectious Diseases Pharmacists”",
keywords = "United States, Cystic Fibrosis/drug therapy, Humans, Pharmacy, Critical Care, beta-Lactams, Pharmacists, Communicable Diseases, Consensus, Anti-Infective Agents",
author = "Hong, \{Lisa T.\} and Downes, \{Kevin J.\} and Alireza FakhriRavari and Abdul-Mutakabbir, \{Jacinda C.\} and Kuti, \{Joseph L.\} and Sarah Jorgensen and Young, \{David C.\} and Alshaer, \{Mohammad H.\} and Matteo Bassetti and Bonomo, \{Robert A.\} and Mark Gilchrist and Jang, \{Soo Min\} and Thomas Lodise and Roberts, \{Jason A.\} and Thomas T{\"a}ngd{\'e}n and Athena Zuppa and Scheetz, \{Marc H.\}",
year = "2024",
month = feb,
doi = "10.1002/phar.2907",
language = "English",
volume = "44",
pages = "208--209",
journal = "Pharmacotherapy",
issn = "0277-0008",
number = "2",
}